Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants
Completed · Phase 2/Phase 3
Conditions studied: Anemia
In brief
The purpose of this study is to determine if iron supplementation in addition to routine iron intake decreases the risk of developing anemia in preterm infants.
Key facts
- Study ID
- NCT01224236
- Run by
- The University of Texas Health Science Center, Houston
- People needed
- 150
- Starts
- 2010-07-01
- Expected to finish
- 2012-02-01
- Last updated by the study team
- 2015-06-19
Who can join
Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- birth weight: < 1500 grams
- Tolerating iron fortified preterm formula or fortified breast milk at 120cc/kg/day by 8 weeks of age
- ≤32 weeks adjusted post-menstrual age at the time of enrollment
You may not qualify if…
- cyanotic heart disease
- bowel resection prior to enrollment
Where it is running
- Children's Memorial Hermann Hospital — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.